First in class Anabolic Catabolic Transforming Agent
MT-102 is a small molecule therapeutic that has a unique combination of pharmacological effects to produce an Anabolic Catabolic Transforming Agent (ACTA) with an excellent safety and efficacy profile. The human safety profile of MT-102 has been demonstrated in two phase I/II clinical studies. The preclinical efficacy profile has been demonstrated in animal models of both cachexia and sarcopenia.
More Info ยป